山东省眼科医院
医院概览
山东省眼科医院于2004年由中国工程院院士---谢立信教授创办，是山东省委省政府做大做强 “山东大眼科”，发挥院士效应的重要举措，是山东省眼科研究所“做大做强”的重要步骤，也是国内最大的集医疗、教学、科研、防盲为一体的国有省级三级甲等眼科专科医院之一。
作为院士单位，我院具备国内突出、省内领先的人才、技术、科研优势。医院由院士创办，亚洲角膜病协会副主席以及中华医学会眼科学分会常委、角膜病学组组长由我院专家担任。省内眼科唯一的山东省医学领军人才亦在我院。
医院是我国角膜病诊疗、科研的龙头单位，全国最主要的角膜移植手术中心之一。在各种眼烧伤、角膜感染、圆锥角膜、飞秒激光辅助的角膜移植、内皮移植等疑难角膜病治疗方面具有突出的专家、技术优势和创新能力。是国内唯一出版角膜病系列专著（前后共5部，500余万字）的单位。还是国内疑难白内障、儿童白内障、视网膜眼底疾病诊疗的重要基地，是国内极少数能够完成眼部大贯穿手术（角膜移植联合玻璃体切除治疗复杂眼外伤等眼前后段联合手术）的单位之一。
在世界眼科领域权威学术杂志《Ophthalmology》发表文章10余篇，排行国内第一。凭借在角膜及眼表手术方面的多项创新，荣获国家科技进步二等奖2项，是近20年来省内唯一获得2项国家科技进步奖二等奖的单位。
自2008年起，医院先后被省有关部门批准为山东省眼科临床专业质量控制中心、山东省眼科医学临床中心、山东省角膜病防治与功能重建技术工程中心；国家住院医师规范化培训基地，亚洲角膜病协会（Asia Cornea Society）国际住院医师培训单位。
设施设备
现有业务用房3万平米，核定床位数142张。投资2亿元建成的亚洲最大的角膜病防治中心----山东省角膜病防治研究中心已投入使用。20年来，医院已累计从美国、德国、日本等地引进国际先进的大型眼科检查、治疗和手术设备500余台(套)。年均投入千万元用于设备、设施的更新、维护，医疗服务硬件水平始终处于国内领先、国际先进水平。
人才优势
在谢立信院士的引领下，医院职工200余名，其中卫生专业技术人员150余人。建成了一支由山东省医学领军人才、山东省有突出贡献的中青年专家、山东省泰山学者攀登计划专家为代表的中高级专业技术人员梯队。医师总数70余人，高级职称医师15名，30%以上医生具有国外留学经历和博士学历，硕士及以上学位人员占比超70%。医院历来重视高端人才的培养与引进。近五年来，先后引进国内知名医学院校的博士学历人员10余位。
医院业已形成了以谢立信院士领军，史伟云教授（国家级行业领军人物）为带头人，以省级各专业知名专家为骨干，以博士研究生学历的青年专家为主体，以一批具有研究生学历的青年为基础，年富力强的临床人才队伍；具有山东大学、青岛大学、济南大学博士、硕士研究生导师资格10余人，形成了一支潮气蓬勃的教师队伍。为医院长远发展奠定了坚实基础。
医疗服务
开设有角膜病、白内障、眼底病（内、外）、青光眼、眼肌屈光、眼眶病眼整形、角膜屈光科、验光配镜（含塑形镜验配）等临床专业科室。门诊设有知名专家门诊、专家门诊、博士门诊、专业门诊，满足各类患者就诊需要。可诊治各种眼科常见和疑难病。年均接诊来自全国30余个省市地区眼病患者10万余人次。
医院是国内较早开展各类角膜移植手术、白内障超声乳化联合人工晶状体植入术、青光眼手术、眼底手术、近视激光矫正术的医院之一，年均完成各类手术10000余例。相关技术均达到国内领先、国际先进水平。
特色专长
角膜病专业：我国角膜病诊疗、科研的龙头单位，全国最主要的角膜移植手术中心之一。我院专家长期担任中华眼科学分会角膜病学组（代表我国角膜病学术最高水平的团体）组长。凭借在各种眼部酸碱热烧伤，真菌、细菌、病毒、棘阿米巴等角膜感染，圆锥角膜、飞秒激光辅助的角膜移植、内皮移植等疑难角膜病方面的突出的专家、技术优势和创新能力，依托国内最大的省级红十字眼库（也是国内首批国际合作眼库），我院年均提供千余只临床用角膜材料，每年为来自全国的疑难角膜病患者20000余人解除病痛；完成各类疑难角膜移植手术1000余台，占全国角膜移植手术总量的1/5。
白内障及视网膜专业：常年开展各种复杂的白内障摘除手术，特别是角膜不透明、角膜内皮细胞数低的高危白内障手术；开创白内障摘除联合25G玻切头扁平部玻璃体切除术治疗儿童白内障手术。该手术是现今国内眼科界公认最有效、复发率最低的儿童先天性白内障手术治疗方式。现开展的老年性黄斑变性、早中晚期糖尿病性视网膜病变、各种类型视网膜脱离，各种累及眼后段的眼外伤和眼内感染，各种病因导致的眼底出血以及早产儿视网膜病变的诊断和治疗也居国内领先水平。激光和手术治疗糖尿病视网膜病变、手术治疗各种复杂的视网膜脱离、严重眼外伤和眼内感染在国内具备突出的优势。医院依托在角膜病领域无可比拟的超强技术实力，是国内极少数能够完成眼部大贯穿手术（角膜移植联合玻璃体切除治疗复杂眼外伤等眼前后段联合手术）和利用飞秒激光开展各类个体化近视、散光矫正手术的医疗机构之一。
科研成果
2011年以来，获得国家和省部级课题资助60余项，科研经费合计2500余万元。凭借在角膜及眼表手术方面的多项创新，荣获国家科技进步二等奖2项，山东省科技进步一等奖等省部级奖励10余项，居国内前五，省内之首。
发表学术论文300余篇，其中SCI收录论著133篇，包括Cell Discovery、PNAS、Diabetes等杂志。在世界眼科领域权威学术杂志《Ophthalmology》发表论文10余篇；出版有国内唯一的角膜病系列专著一套5本：《角膜病学》《角膜移植学》、《角膜病图谱》、《临床角膜病学》、《角膜手术学》，还联合中华医学会、人民卫生出版社联合出版《角膜移植手术集锦》《先天性白内障手术治疗》《常用眼表手术》《眼前段常规检查技术》等教学光盘和译著15部。
社会公益
常年深入社区、学校、农村开展眼科科普义诊、近视防控筛查及扶贫助困活动，在全省范围内承揽山东省红十字会“博爱齐鲁”白内障复明救助项目。10余年来累计开展活动近7000场次，义诊群众超21万余人，开展公益救助手术1.1万余台，减免各类诊疗、手术费用4300余万元。
2009年，医院与山东省红十字会联合成立了角膜捐献接收组织库--山东省红十字眼库。2020年，山东省卫健委依托我院设置山东省眼库。深度参与全省角膜捐献接收、宣传、志愿服务等工作。现年均完成角膜捐献接收300余例，是国内最大的角膜组织专库之一。
宗旨目标
自建院起，发扬“热爱专业”的专注精神，艰苦奋斗，坚持自主创新，树立“为了人类光明”的信念，始终秉持以病人为中心的核心理念，以人为本，以医疗、科研为重心；不断发挥人才、技术、设备优势，吸收国际先进的管理经营理念；赢得了来自国内外眼病患者的信赖。医院将始终朝着建设服务好、质量好、医德好，群众满意，技术先进、规模适度的国内领先、国际知名的眼科综合体不断前进。
院领导班子：
法人代表：史伟云
院 长：史伟云
副 院 长：高 华
副 院 长：王 婷
副 院 长：亓晓琳
副 院 长：王富华
副 院 长：原公强
总会计师：吉敦亮
Hospital Overview
Shandong Eye Hospital was founded in 2004 by Professor Lixin XIE,an academician of the Chinese Academy of Engineering in ophthalmology, which is an important measure taken by Shandong Provincial Committee and Provincial Government to enlarge and strengthen the “Big Ophthalmology in Shandong” and to increase the Academician Effect, and also a significant step of Shandong Eye Institute to “grow bigger and stronger”. Shandong Eye Hospital is one of the largest state-owned provincial-level Third-grade Class-A specialized eye hospital in China that integrates medical treatment, teaching, scientific research and blindness prevention.
Led by the academician, our hospital has advantages of talents, technology and scientific research, which is prominent in the country and leading in the province. Our hospital was founded by the academician; an expert of our hospital is the vice chairman of the Asia Cornea Society, a member of the Standing Committee of the Ophthalmological Society of Chinese Medical Association and the leader of the Corneal Disease Group. The only specially-invited expert of leading medical talents in Shandong Province also work in our hospital.
The hospital is a leading unit in keratopathy diagnosis, treatment and research in China, and one of the most important corneal transplantation centers in China. Our hospital has outstanding specialists, technical advantages and innovative ability in the treatment of various eye burns, corneal infections, keratoconus, femtosecond laser-assisted corneal transplantation, endothelial transplantation and many other difficult keratopathies. Our hospital is the only unit in China that has published a series of monographs of corneal diseases (a total of 5 monographs, more than 5 million words). It is also an important base for the diagnosis and treatment of difficult cataracts, pediatric cataracts and retinal fundus oculi diseases in China. Our hospital is one of the few hospitals in China that can complete the major surgery of eyes (corneal transplantation combined with vitrectomy for the treatment of complex ocular trauma and other anterior and posterior segment combined surgeries).
Experts of our hospital have published more than 10 papers in Ophthalmology, a TOP academic journal in ophthalmology, ranking first in China. With many innovations in corneal and ocular surface surgeries, our hospital has won two Second Prize in the National Science and Technology Progress Award, being the only one in Shandong province that has won two Second Prize in the National Science and Technology Progress Award in the past 20 years.
Since 2008, our hospital has been approved by the provincial authorities as Shandong Provincial Quality Control Center for Clinical Ophthalmology, Shandong Provincial Medical Center for Clinical Ophthalmology, Shandong Provincial Technological Engineering Center for Corneal Disease Prevention and Functional Reconstruction, National Standardized Training Base for Resident Physician, International Resident Physician Training Unit of Asia Cornea Society.
Facilities and Equipment
Our hospital now has 30,000 square meters for business purpose and 200 opening beds. Shandong Corneal Disease Prevention and Treatment Research Center, the largest corneal disease prevention and treatment center of Asia, built with an investment of 200 million yuan, has been put into use.
Over the past 10 years, our hospital has introduced more than 500 sets of internationally advanced ophthalmic exam, treatment and surgical equipment from the United States, Germany and Japan. An annual investment of 10 million yuan is used for the renewal and maintenance of equipment and facilities. The hardware level of medical services has always been at the leading level in the country and at the advanced level internationally.
Talent Advantage
Under the guidance of Academician Lixin XIE, our hospital has more than 200 employees, more than 150 of whom are medical professionals. A team of mid-level and high-level professionals represented by the leading medical talents in Shandong Province, the young and middle-aged experts with outstanding contributions in Shandong Province and the experts of Taishan Scholar Program of Shandong Province has been built. There are more than 70 physicians in total and 15 of them have senior professional titles. More than 30% of our doctors have foreign study experience and doctoral degree, and over 70% of our doctors have master's degree or above. The hospital has always attached great importance to the cultivation and introduction of high-end talents. In the past five years, our hospital has introduced more than 10 professionals graduated from well-known medical colleges and universities in China with doctoral degree.
With the guidance of Academician Lixin XIE, the hospital has also formed a young and dynamic team of clinical professionals with Professor Weiyun SHI (national industry leader) as the leader, provincial-level leading experts as the backbone, young experts with doctoral degree as the main body and a group of young professionals with master’s degree as the foundation. More than 10 doctors in our hospital are qualified doctoral supervisor or master’s supervisor of Shandong University, Qingdao University or Jinan University, forming a team of teachers full of vigor and vitality. The teams are the solid foundations for the long-term development of our hospital.
Medical Services
Our hospital has many clinical departments, including corneal disease, cataract, fundus disease (internal and external), glaucoma, eye muscle refraction, oculoplastic & orbital surgery, corneal refraction, optometry (including providing optometry services of orthokeratology). Our well-known expert clinics, expert clinics, doctoral clinics and professional clinics can meet the needs of different patients. Our qualified doctors can diagnose and treat a variety of common and difficult ophthalmic diseases. The annual average number of patients with eye diseases coming to our hospital for treatment from more than 30 provinces and cities all over China is more than 100,000.
Our hospital is one of the hospitals in China where various types of corneal transplantation, phacoemulsification combined with intraocular lens implantation, glaucoma surgery, fundus surgery and laser myoporthosis are early performed. More than 10,000 cases of various types of surgeries have been completed annually. The relevant technologies have reached a leading level in the country and an advanced level internationally.
Characteristics and Speciality
Corneal disease subspecialty: Our hospital is a leading unit in the diagnosis, treatment and scientific research of corneal disease in China, and is also one of the most important corneal transplantation centers in China. One of our experts has long served as the leader of the Corneal Disease Group of Ophthalmological Society of Chinese Medical Association (the group representing the highest academic level in corneal diseases in China). With the outstanding experts, technological superiority and innovation ability in various acid, alkali and thermal burns around eyes, corneal infections caused by fungi, bacteria, viruses and acanthamoeba, and difficult corneal diseases including keratoconus, femtosecond laser-assisted corneal surgeries and endothelium transplantation, supported by the largest provincial red cross eye bank in our country (also the first batch of international cooperation eye bank in China), our hospital provides more than a thousand corneal materials for clinical use annually and relieves the pain for more than 20,000 patients with complicated corneal diseases from all over the country every year. Our hospital has completed more than 1,000 various corneal transplantation surgeries, accounting for 20% of the total corneal transplantation surgeries in China.
Cataract and retina subspecialties: Our hospital performs various kinds of difficult cataract surgeries all year round, especially the high-risk cataract surgeries for opaque corneas and corneas with low endothelial cells counts. Our hospital has initiated cataract extraction combined with 25G pars plana vitrectomy for children with cataract, which is now considered as the most effective surgical treatment, with the lowest risks, for children with congenital cataract in ophthalmology in China. Our diagnosis and treatment for age-related macular degeneration, early, middle and late stages of diabetic retinopathy, various types of retinal detachments, various eye traumas and intraocular infections involving the posterior segment, fundus hemorrhage resulting from various causes and retinopathy of prematurity are leading in China. In the treatment of diabetic retinopathy with laser and surgery, surgical treatment of various difficult retinal detachments, severe eye traumas and intraocular infections, our hospital has outstanding advantages in China. Relying on the incomparable strong technical strength in the field of corneal diseases, our hospital is one of the few medical institutions in China that can perform the major surgery of the eye (corneal transplantation combined with vitrectomy for the treatment of complex ocular trauma and other anterior and posterior segment combined surgeries) and can complete various types of individualized myopia and astigmatism correction surgeries using the femtosecond laser.
Scientific Research Achievements
Since 2011, our hospital has received more than 60 national level and provincial level project funds, more than 25 million yuan for scientific research in total. With the innovations in corneal and ocular surface surgeries, our hospital has won two Second Prize in the National Science and Technology Progress Award and more than ten provincial-level awards including a First Prize in the Shandong Science and Technology Progress Award, ranking top five in China and the first in Shandong province.
Our doctors have published more than 300 academic papers, 133 of which are included in SCI, including Cell Discovery, PNAS (IF: 9.809), Diabetes (IF:8.474) and so on. 12 papers were published in Ophthalmology, the TOP academic journal in ophthalmology.
Our experts have published the only series of monographs on keratopathy in China, including 5 monographs: Cornea, Corneal Transplantation, Corneal Atlas, Clinical Cornea, Surgery of the Cornea and have jointly published 15 teaching CDs and translations such as Collection of Outstanding Corneal Transplant Surgeries, Surgical Treatment of Congenital Cataract, Common Ocular Surface Surgeries and Routine Examination Techniques of Anterior Segment with Chinese Medical Association and People's Medical Publishing House.
Public Interest Activities
Our hospital implements activities helping and supporting the poor in communities and rural areas all year round and has carried out a cataract relief activity called “Great Love in Qilu” in conjunction with Shandong Branch of Red Cross Society of China, covering the whole province. Over the past 10 years, we have helped more than 500 economically disadvantaged families and reduced and remitted more than 3 million diagnosis, treatment and surgery fees.
In 2009, our hospital jointly established a tissue bank for cornea donation and reception with Shandong Branch of Red Cross Society of China, called Eye Bank of Shandong Red Cross, being responsible for the cornea donation and reception work in the 17 cities of Shandong province and assisting the publicity and voluntary services of cornea donation. Our hospital receives about 200 cases of cornea donations annually in Shandong province, making us the biggest cornea tissue bank in China.
Missions and Objectives
Since the establishment of our hospital, we have carried forward the spirit of “loving my profession”, worked hard, attached great importance to independent innovation, developed the belief of “fighting for healthy vision”, adhered to the patient-centered core idea and people-oriented principle and focused on medical treatment and scientific research. We have also taken full advantage of the talents, technology and facilities and learnt internationally advanced management concepts. All these efforts have helped us win trust from patients at home and abroad. In the future, our hospital will endeavor unremittingly to evolve into a domestically leading and internationally renowned eye institution that can provide good and high-quality services and have noble medical ethics, advanced technology and moderate scale to satisfy the patients.
Leaders of our hospital:
Legal representative: Weiyun SHI
President: Weiyun SHI
Vice president: Hua GAO
Vice president: Ting WANG
Vice president: Xiaolin QI
Vice president: Fuhua WANG
Vice president: Gongqiang YUAN
General accountant: Dunliang JI
组织架构:
医院实景图：
单位资质：
